Common Contracts
4 similar Supplemental Stock Issuance Agreement contracts by Fibrocell Science, Inc., Intrexon Corp
EX-10.2 3 d562334dex102.htm EX-10.2 SUPPLEMENTAL STOCK ISSUANCE AGREEMENTSupplemental Stock Issuance Agreement • May 5th, 2020 • Delaware
THIS SUPPLEMENTAL STOCK ISSUANCE AGREEMENT (“Agreement”) is made and entered into as of June 28, 2013 (the “Effective Date”), by and among Fibrocell Science, Inc., a Delaware corporation (the “Company”) and Intrexon Corporation, a Virginia corporation (“Intrexon”).
SUPPLEMENTAL STOCK ISSUANCE AGREEMENTSupplemental Stock Issuance Agreement • January 13th, 2014 • Intrexon Corp • Services-commercial physical & biological research • Delaware
THIS SUPPLEMENTAL STOCK ISSUANCE AGREEMENT (“Agreement”) is made and entered into as of January 10, 2014 (the “Effective Date”), by and among Fibrocell Science, Inc., a Delaware corporation (the “Company”) and Intrexon Corporation, a Virginia corporation (“Intrexon”).
SUPPLEMENTAL STOCK ISSUANCE AGREEMENTSupplemental Stock Issuance Agreement • January 13th, 2014 • Fibrocell Science, Inc. • Pharmaceutical preparations • Delaware
THIS SUPPLEMENTAL STOCK ISSUANCE AGREEMENT (“Agreement”) is made and entered into as of January 10, 2014 (the “Effective Date”), by and among Fibrocell Science, Inc., a Delaware corporation (the “Company”) and Intrexon Corporation, a Virginia corporation (“Intrexon”).
SUPPLEMENTAL STOCK ISSUANCE AGREEMENTSupplemental Stock Issuance Agreement • July 1st, 2013 • Fibrocell Science, Inc. • Pharmaceutical preparations • Delaware
THIS SUPPLEMENTAL STOCK ISSUANCE AGREEMENT (“Agreement”) is made and entered into as of June 28, 2013 (the “Effective Date”), by and among Fibrocell Science, Inc., a Delaware corporation (the “Company”) and Intrexon Corporation, a Virginia corporation (“Intrexon”).
